holmium Ho 166 DOTMP

RADIATION4 trials

Sponsors

Fred Hutchinson Cancer Center, Poniard Pharmaceuticals

Conditions

Metastatic CancerMultiple Myeloma and Plasma Cell NeoplasmSarcoma

Phase 1

Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone

CompletedNCT00006234

Fred Hutchinson Cancer CenterMetastatic Cancer, Sarcoma

Start: 2001-11-30End: 2006-03-31Updated: 2011-12-01

Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

CompletedNCT00045136

Poniard PharmaceuticalsMultiple Myeloma and Plasma Cell Neoplasm

Start: 2002-01-31Updated: 2009-04-03

Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

CompletedNCT00004158

Fred Hutchinson Cancer CenterMultiple Myeloma and Plasma Cell Neoplasm

Start: 1999-06-30End: 2006-01-31Updated: 2010-09-21

Phase 3

Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

CompletedNCT00008229

Fred Hutchinson Cancer CenterMultiple Myeloma and Plasma Cell Neoplasm

Start: 2000-08-31End: 2001-09-30Updated: 2010-09-21